InvVax, Inc.
InvVax has discovered fifteen ideal regions of influenza virus to target with a vaccine, preventing the ability of the virus to escape by mutation.
- Stage $500K in TTM Revenue
- Industry Biotechnology
- Location Pasadena, CA, USA
- Currency USD
- Founded January 2013
- Employees 1
- Incorporation Type C-corp
- Website inv-vax.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.